首页> 外文会议>SPIE Photonics Europe Conference >Recognition of Blastic Cells in Human Peripheral Blood by Diffraction Phase Microscopy
【24h】

Recognition of Blastic Cells in Human Peripheral Blood by Diffraction Phase Microscopy

机译:衍射相显微镜识别人外周血中的塑性细胞

获取原文

摘要

Acute lymphoblastic leukemia (ALL) is a type of cancer caused by the disordered growth of white blood cells, known as lymphomas, which are formed in the bone marrow and rapidly diffuse through the bloodstream; affecting other organs and eventually leading to death. Diagnostic tests currently implemented require a cytometric analysis of bone marrow extraction or peripheral blood marking for counting of blastic cells present in peripheral blood via light microscopy. These techniques are invasive, requiring labeling and alteration of cells. Therefore, an alternative technique is sought by implementing a diffraction phase microscope (DPM), which allows the measurement of the size and refractive index variations of the cells in a non-invasive way, looking for the detection of blast cells in human peripheral blood. In a first phase it is necessary to distinguish blastic cells from other mononuclear cells such as T and B lymphocytes and monocytes. The present work describes the implementation of the technique in order to establish parameters of population differentiation, morphometric and refractive index of mononuclear cells and blast cells in a single blood sample. For this purpose it is described the process of separation of peripheral blood mononuclear cell populations and cells from two diseased donors are analyzed. Consequently, the DPM technique is validated as a differentiation parameter, opening the way to the possibility of validating it for the diagnosis of ALL in the analysis of a sample of human peripheral blood.
机译:急性淋巴细胞性白血病(ALL)是一种由白细胞生长紊乱引起的癌症,这种白细胞被称为淋巴瘤,形成于骨髓中,并迅速扩散通过血液。影响其他器官并最终导致死亡。当前实施的诊断测试需要对骨髓提取物或外周血标记物进行细胞计数分析,以通过光学显微镜对存在于外周血中的回弹细胞进行计数。这些技术是侵入性的,需要标记和改变细胞。因此,通过实现衍射相显微镜(DPM)寻求一种替代技术,该技术允许以非侵入性的方式测量细胞的大小和折射率变化,以寻找人外周血中的原始细胞的检测。在第一阶段,有必要将胚细胞与其他单核细胞(如T和B淋巴细胞和单核细胞)区分开来。本工作描述了该技术的实现,以建立单个血样中单核细胞和胚细胞的群体分化,形态和折射率的参数。为此目的,描述了分离外周血单个核细胞群的过程,并分析了来自两个患病供体的细胞。因此,DPM技术被作为区分参数进行了验证,从而为在分析人类外周血样品中诊断ALL时进行验证的可能性开辟了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号